BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15259766)

  • 1. A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids.
    Waisser K; Drazková K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2004; 49(3):265-8. PubMed ID: 15259766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
    Waisser K; Drazková K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
    Waisser K; Drazková K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Derivatives of phenylcarbamic acid as potential antituberculotics].
    Waisser K; Cizmárik J
    Ceska Slov Farm; 2012 Feb; 61(1-2):17-20. PubMed ID: 22536648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
    Waisser K; Cizmárik J; Drazková K; Kaustová J
    Ceska Slov Farm; 2002 May; 51(3):140-4. PubMed ID: 12058355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
    Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
    Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antimycobacterial derivatives of benzoxazine.
    Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
    Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
    Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
    Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
    Waisser K; Holý P; Bures O; Kunes J; Kaustová J
    Ceska Slov Farm; 2003 Jan; 52(1):42-7. PubMed ID: 12685334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
    Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
    Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New S-benzylisothiosemicarbazones with antimycobacterial activity.
    Petrlíková E; Waisser K; Heinisch L; Stolaříková J
    Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
    Waisser K; Adamec J; Dolezal R; Kaustová J
    Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High active potential antimycobacterial agents against Mycobacterium avium.
    Karel W; Jiří K; Jiřina S
    Ceska Slov Farm; 2012 Jun; 61(3):127-9. PubMed ID: 22913828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of natural and semi-synthetic lignans.
    Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
    Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
    Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
    Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules.
    Rychtarčíková Z; Krátký M; Gazvoda M; Komlóová M; Polanc S; Kočevar M; Stolaříková J; Vinšová J
    Molecules; 2014 Mar; 19(4):3851-68. PubMed ID: 24686575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.